The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysis

BACKGROUND: Affordability to novel anticancer drugs has become a major health issue in China. It is encouraging to note that China initiated its drug regulatory reform and national price negotiation policies since 2015. As a growing number of domestic within-class targeted anticancer drugs are appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xingxian, Du, Xin, Huang, Lin, Guo, Qixiang, Tan, Ruijie, Zhou, Yue, Li, Zhuangqi, Xue, Xuecai, Li, Taifeng, Le, Kaidi, Qian, Feng, Chow, Shein-Chung, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918802/
https://www.ncbi.nlm.nih.gov/pubmed/36785854
http://dx.doi.org/10.1016/j.lanwpc.2022.100670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918802/
https://www.ncbi.nlm.nih.gov/pubmed/36785854
http://dx.doi.org/10.1016/j.lanwpc.2022.100670

Ejemplares similares